Fetal grafting for Parkinson's disease: Expression of immune markers in two patients with functional fetal nigral implants

Cell Transplantation

Volumn 6, Issue 3, 1997, Pages 213-219

  Kordower, Jeffrey H ^a   Styren, Scot ^b   Clarke, Martha ^b   Dekosky, Stephen T ^b   Olanow, C Warren ^c   Freeman, Thomas B ^d  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

B Cells; Cyclosporin; Macrophages; T Cells; Ventral mesencephalon

Indexed keywords

CYCLOSPORIN; HLA DR ANTIGEN;

ARTICLE; AUTOPSY; B LYMPHOCYTE; CASE REPORT; DOPAMINERGIC NERVE CELL; FETAL TISSUE TRANSPLANTATION; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; HUMAN TISSUE; IMMUNOCOMPETENT CELL; MACROPHAGE; NERVE TRANSPLANTATION; PARKINSON DISEASE; PRIORITY JOURNAL; T LYMPHOCYTE;

ANTIBODY SPECIFICITY; B-LYMPHOCYTES; BIOLOGICAL MARKERS; BRAIN TISSUE TRANSPLANTATION; CORPUS STRIATUM; FATAL OUTCOME; FETAL TISSUE TRANSPLANTATION; GRAFT SURVIVAL; HLA-DR ANTIGENS; HUMANS; IMMUNOHISTOCHEMISTRY; MICROGLIA; PARKINSON DISEASE; T-LYMPHOCYTES;

EID: 0031010545     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0963-6897(97)00019-5     Document Type: Article

References (48)

1. Brundin, P.; Bjorklund, A. Survival, growth and function of dopaminergic neurons grafted to the brain. Prog. Brain Res. 71:293-308; 1987.
2. Brundin, P.; Strecker, R.E.; Widner, H.; Clarke, D.J.; Nilsson, O.G.; Astedt, B.; Lindvall, O.; Björklund, A. Human fetal dopamine neurons grafted in a rat model of Parkinson's disease: Immunological aspects, spontaneous and drug-induced behavior, and dopamine release. Exp. Brain Res. 70:192-208; 1988.
3. Brundin, P.; Strecker, D.J.; Clarke, D.J.; Widner, H.; Nilsson, O.G.; Astedt, B.; Lindvall, O.; Björklund, A. Can human fetal dopamine neuron grafts provide a therapy for Parkinson's disease? In: Gash, D.M.; Sladek, J.R., eds. Progress in brain research, Elsevier, Amsterdam 78:441-448; 1988.
4. Date, I.; Kawamura, K.; Nakashima, H. Histological signs of immune reactions against allogeneic solid fetal neural grafts in the mouse cerebellum depend on the MHC locus. Exp. Brain Res. 73:15-22; 1988.
5. DeKosky, S.T.; Styren, S.D.; O'Malley, M.E.; Goss, J.R.; Kochnek, P.M.; et al. Interleukin-1 receptor antagonist suppresses neurotrophin response in injured rat brain. Ann. Neurol. 39:123-127; 1996.
6. Duan, W.-M.; Widner, H.; Frodl, E.M.; Brundin, P. Immune reactions following systemic immunization prior or subsequent to intrastriatal transplantation of allogeneic mesencephalic tissue in adult rats. Neuroscience 64:629-641; 1995.
7. Duan, W.-M.; Widner, H.; Björklund, A.; Brundin, P. Sequential intrastriatal grafting of allogeneic embryonic dopamine-rich neuronal tissue in adult rats: Will the second graft be rejected? Neuroscience 57:261-274; 1993.
8. Freed, C.R.; Breeze, P.M.; Rosenberg, N.L.; Schneck, S.A.; Wells, T.H.; Barrett, J.N.; Grafton, S.T.; Huang, S.C.; Eidelberg, D.; Rottenberg, D.A. Transplantation of human fetal dopamine cells for Parkinson's disease. Results at one year. Arch. Neurol. 47:505-512; 1990.
9. Freed, C.R.; Breeze, P.M.; Rosenberg, N.L.; Schneck, S.A.; Kriek, E.; Qi, J.-X.; Lone, T.; Zhang, Y.-B.; Snyder, J.; Wells, T.; Ramig, L.O.; Thompson, L.; Mazziotta, J.C.; Huang, S.C.; Grafton, S.T.; Brooks, D.; Sawle, G.; Schroter, G.; Ansari, A.A. Survival of implanted fetal dopamine cells and neurological improvement 12 to 46 months after transplantation for Parkinson's disease. N. Engl. J. Med. 327:1549-1553; 1992.
10. Freeman, T.B.; Olanow, C.W.; Hauser, R.A.; Nauert, G.M.; Smith, D.A.; Borlongan, C.V.; Sanberg, P.R.; Holt, D.A.; Kordower, J.H.; Vingerhoets, F.J.G.; Snow, B.J.; Calne, D.; Gauger, L. Bilateral fetal nigral transplantation into the post-commissural putamen as a treatment for Parkinson's disease: Six month follow-up. Ann. Neurol. 38: 379-388; 1995.
11. Griffin, W.S.T.; Stanely, L.C.; Ling, C.; White, L.; Macleod, V., et al. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down Syndrome and Alzheimer's disease. Proc. Natl. Acad. Sci. USA 86:7611-7615; 1989.
12. Head, J.R.; Griffin, W.S. Functional capacity of solid tissue transplants in the brain: Evidence for immunological privilege. Proc. R. Soc. Lond. B [Biol. Sci.] 224:375-387; 1985.
13. Henderson, B.T.H.; Clough, C.G.; Hughes, R.C.; Hitchcock, E.R.; Kenny, B.G. Implantation of human ventral mesencephalon to the right caudate nucleus in advanced Parkinson's disease. Arch. Neurol. 48:822-827; 1991.
14. Hitchcock, E.R.; Clough, C.; Hughes, R.; Kenny, B. Embryos and Parkinson's disease. Lancet 1:1274-1276; 1988.
15. Hsu, S.M.; Raine, L.; Fanger, H. Use of avidin-biotin peroxidase complex (ABC) in immunoperoxidase techniques. A comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem. 29:577-580; 1981.
16. Huang, S.; Pei, G.; Kang, F.A. Transplant operation of human fetal substantia nigra tissue to caudate nucleus in Parkinson's disease: First clinical trials. Chinese J. Neurosurg. 5:210-213; 1989.
17. Isono, M.; Poltorak, M.; Kulaga, H.; Adams, A.J.; Freed, W.J. Certain host-donor strain combinations do not reject brain allografts after systemic sensitization. Exp. Neurol. 122:48-56; 1993.
18. Kordower, J.H.; Freeman, T.B.; Snow, B.J.; Vingerhoets, F.J.G.; Mufson, E.J.; Sanberg, P.R.; Hauser, R.A.; Smith, D.A.; Nauert, G.M.; Perl, D.P.; Olanow, C.W. Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N. Engl. J. Med. 332:1118-1124; 1995.
19. Kordower, J.H.; Rosenstein, J.M.; Collier, T.J.; Burke, M.A.; Chen, E.-Y.; Li, J.M.; Martel, L.; Levey, A.E.; Mufson, E.J.; Freeman, T.B.; Olanow, C.W. Functional fetal nigral grafts in a patient with Parkinson's disease: Chemoanatomic, ultrastructural, and metabolic studies. J. Comp. Neurol. 370:203-230; 1996.
20. Kordower, J.H.; Rosenstein, J.M.; Collier, T.J.; Chen, E.-Y.; Li, J.L.; Mufson, E.J.; Sanberg, P.; Freeman, T.B.; Olanow, C.W. Functional fetal nigral implants in a second patient with Parkinson's disease: A post-mortem analysis. Soc. Neurosci. Abstr. 22:318; 1996.
21. Lawrence, J.M.; Morris, R.J.; Wilson, D.J.; Raisman, G. Mechanisms of allograft rejection in the rat brain. Neuroscience 37:431-462; 1990.
22. Lindvall, O.; Brundin, P.; Widner, H.; Rehncrona, S.; Gustavii, B.; Frackowiak, R.; Leenders, K.L.; Sawle, G.; Rothwell, J.C.; Marsden, C.D.; Björklund, A. Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science 247:574-577; 1990.
23. Lindvall, O.; Widner, H.; Rehncrona, S.; Brundin, P.; Odin, P.; Gustavii, B.; Frackowiak, R.; Leenders, K.L.; Sawle, G.; Rothwell, J.C.; Björklund, A.; Marsden, C.D. Transplantation of fetal dopamine neurons in Parkinson's disease: One-year clinical and neurophysiological observations in two patients with putaminal implants. Ann. Neurol. 31:155-165; 1992.
24. Lindvall, O.; Sawle, G.; Widner, H.; Rothwell, J.C.; Björklund, A.; Brooks, D.; Brundin, P.; Frackowiak, R.; Marsden, C.D.; Odin, P. Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease. Ann. Neurol. 35:172-180; 1994.
25. Lindvall, O.; Rehncrona, S.; Brundin, P.; Gustavii, B.; Astedt, B.; Widner, H.; Lindholm, T.; Björklund, A.; Leenders, K.L.; Rothwell, J.C.; Marsden, C.D. Human fetal dopamine neurons grafted into the striatum in two patients with Parkinson's disease: A detailed account of methodology and 6 month follow-up. Arch. Neurol 46:615-631; 1989.
26. Lindvall, O. Prospects of transplantation in human neurodegenerative diseases. Trends Neurosci. 14:376-384; 1991.
27. Lopez-Lozana, J.J.; Bravo, G.; et al. Can an analogy be drawn between the clinical evolution of Parkinson's disease patient who undergo autoimplantation of adrenal medulla and those of fetal ventral mesencephalon transplant recipients? In: Björklund, A.; Widner, H., eds. Transplantation in movement disorders. Amsterdam: Elsevier Science Publishers; 1993:87-98.
28. Low, W.C.; Lewis, P.R.; Terri, S.T. Embryonic neural transplants across a major histocompatibility barrier: survival and specificity of innervation. Brain Res. 262:328-333; 1983.
29. Madrazo, I.; Franco-Bourland, R.; Aguilera, M.; Ostrosky-Solis, F.; Madrazo, M.; Cuevas, C.; Catrejon, H.; Guizar-Zahagun, G.; Magallon, E. Autologous adrenal medullary, fetal mesencephalic, and fetal adrenal brain transplantation in Parkinson's: A long-term postoperative follow-up. J. Neural. Transplant. Plast. 2:157-164; 1991.
30. Madrazo, I.; Franco-Bourland, R.; Ostrosky-Solis, F.; et al. Neural transplantation (auto-adrenal, fetal nigral and fetal adrenal) in Parkinson's disease: The Mexican experience. Prog. Brain Res. 82:593-602; 1990.
31. Mason, D.W.; Charlton, H.M.; Jones, A.J.; Lavy, C.B.; Puklavec, M.; Simmonds, S.J. The fate of allogeneic and xenogeneic neuronal tissue transplanted into the third ventricle of rodents. Neuroscience 19:685-694; 1986.
32. Molina, H.; Quinones, R.; Alvarez, L.; et al. Transplantation of human fetal mesencephalic tissue in caudate nucleus as treatment for Parkinson's disease: The Cuban experience. In: Lindvall, O.; Björklund, A.; Widner, H., eds. Intracerebral transplantation in movement disorders: Experimental basis and clinical experiences. Amsterdam: Elsevier; 1991:99-110.
33. Nicholas, M.K.; Antel, J.P.; Stefansson, K.; Amason, B.G. Rejection of fetal neocortical neural transplants by H-2 incompatible mice. J. Immunol. 13:2275-2283; 1987.
34. Nicholas, M.K.; Stefansson, K.; Antel, J.P.; Arnason, B.G. An in vivo and in vitro analysis of systemic immune function in mice with histologic evidence of neural transplant rejection. J. Neurosci. Res. 18:245-257; 1987.
35. Olanow, C.W.; Hauser, R.A. Recent advances in Parkinson's disease. In: Appel, S.H., ed. Current neurology, vol. 12. Mosby Yearbook, 1992:111-154.
36. Olanow, C.W.; Kordower, J.H.; Freeman, T.B. Fetal nigral transplantation for the treatment of Parkinson's disease. Trends Neurosci. 19:83-117; 1996.
37. Peschanski, M.; Defer, G.; N'Guyen, J.P.; Ricolfi, F.; Monfort, J.C.; Remy, P.; Geny, C.; Samson, Y.; Hantraye, P.; Jeny, R. Bilateral motor improvement and alteration of L-dopa effect in two patients with Parkinson's disease following intrastriatal transplantation of foetal ventral mesencephalon. Brain 117:487-499; 1994.
38. Poltorak, M.; Freed, W.J. BN rats do not reject F344 brain allografts even after systemic sensitization. Ann. Neurol. 29:377-388, 1991.
39. Sloan, D.J.; Baker, B.J.; Puklavec, M.; Charlton, H.M. The effect of site of transplantation and histocompatibility differences on the survival of neural tissue transplanted to the CNS of defined inbred rat strains. Prog. Brain Res. 82: 141-152; 1990.
40. Sloan, D.J.; Wood, M.J.; Charlton, H.M. The immune response to intracerebral neural grafts. Trends. Neurosci. 14: 341-346; 1991.
41. Spencer, D.D.; Robbins, R.J.; Naftolin, F.; Marek, K.L.; Vollmer, T.; Leranth, C.; Roth, R.H.; Price, L.H.; Gjedde, A.; Bunney, B.; Sass, K.J.; Elsworth, J.D.; Kier, E.L.; Makuch, R.; Hoffer, P.; Redmond, E., Jr. Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease. N. Engl. J. Med. 327; 1541-1548; 1992.
42. Styren, S.D.; Civin, H.W.; Rogers, J. Molecular, cellular, and pathologic characterization of HLA-DR immunoreactivity in normal elderly and Alzheimer's diseased brain. Exp. Neurol. 110:93-104; 1990.
43. Subrt, O.; Tichy, M.; Vladyka, V.; Hurt, K. Grafting of fetal dopamine neurons in Parkinson's disease: The Czech experience with severe akinetic patients. Acta. Neurochir. Suppl. 52:51-53; 1991.
44. Widner, H.; Tetrud, J.; Rehncrona, S.; Snow, B.; Brundin, P.; Gustavii, B.; Björklund, A.; Lindvall, O.; Langston, J.W. Bilateral fetal mesencephalic grafting in two patients with Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6 tetrahydropyridine (MPTP). N. Engl. J. Med. 327:1556-1660; 1992.
45. Widner, H.; Brundin, P.; Björklund, A.; Moller, E. Survival and immunogenicity of dissociated allogeneic fetal neural dopamine-rich grafts when implanted into the brains of adult mice. Exp. Brain Res. 76:187-197; 1989.
46. Widner, H.; Brundin, P. Immunological aspects of grafting in the mammalian central nervous system. A review and speculative synthesis. Brain Res. 472:287-324; 1988.
47. Widner, H.; Brundin, P. Sequential intracerebral transplantation of allogeneic and syngeneic fetal dopamine-rich neuronal tissue in adult rats: will the first graft be rejected? Cell Transplant. 2:307-317; 1993.
48. Wood, M.J.; Sloan, D.J.; Dallman, M.J.; Charlton, H.M. A monoclonal antibody to the interleukin-2 receptor enhances the survival of neural allografts: A time-course study. Neuroscience 49:409-418; 1992.